Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × SR 48692 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Lung Neoplasms 1

Interventions

Cyclophosphamide 1275 Cisplatin 1214 Radiotherapy 1150 Paclitaxel 1138 Carboplatin 1079 Gemcitabine 1050 Docetaxel 980 Bevacizumab 916 Fluorouracil 769 Doxorubicin 690 Capecitabine 655 Dexamethasone 645 Rituximab 635 Oxaliplatin 602 Etoposide 578 pembrolizumab 565 Irinotecan 551 Filgrastim 540 Cytarabine 504 Leucovorin 500 Nivolumab 481 Vincristine 439 Bortezomib 412 Cetuximab 411 Prednisone 407 Trastuzumab 398 Erlotinib Hydrochloride 398 Surveys and Questionnaires 390 Methotrexate 370 Lenalidomide 364

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00290953 2008-12-23

SESAME

Sanofi

Phase 2/3 Completed

Lung Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡